Bioceres Crop Solutions Corp. (BIOX)

Bioceres Crop Solutions Statistics

Total Valuation

BIOX has a market cap or net worth of $86.54 million. The enterprise value is $321.44 million.

Market Cap	86.54M
Enterprise Value	321.44M

Important Dates

The next estimated earnings date is Monday, November 10, 2025, after market close.

Earnings Date	Nov 10, 2025
Ex-Dividend Date	n/a

Share Statistics

BIOX has 62.71 million shares outstanding. The number of shares has decreased by -0.45% in one year.

Current Share Class	62.71M
Shares Outstanding	62.71M
Shares Change (YoY)	-0.45%
Shares Change (QoQ)	+0.66%
Owned by Insiders (%)	1.96%
Owned by Institutions (%)	15.72%
Float	37.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.25
Forward PS	0.24
PB Ratio	0.27
P/TBV Ratio	6.05
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.96
EV / EBITDA	21.88
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.79
Debt / EBITDA	18.60
Debt / FCF	n/a
Interest Coverage	-0.12

Financial Efficiency

Return on equity (ROE) is -15.90% and return on invested capital (ROIC) is -0.27%.

Return on Equity (ROE)	-15.90%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-0.27%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$856,812
Profits Per Employee	-$133,162
Employee Count	389
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, BIOX has paid $1.30 million in taxes.

Income Tax	1.30M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.24% in the last 52 weeks. The beta is 0.33, so BIOX's price volatility has been lower than the market average.

Beta (5Y)	0.33
52-Week Price Change	-82.24%
50-Day Moving Average	2.53
200-Day Moving Average	4.37
Relative Strength Index (RSI)	21.66
Average Volume (20 Days)	733,169

Short Selling Information

Short Interest	488,173
Short Previous Month	606,638
Short % of Shares Out	0.78%
Short % of Float	1.29%
Short Ratio (days to cover)	0.86

Income Statement

In the last 12 months, BIOX had revenue of $333.30 million and -$51.80 million in losses. Loss per share was -$0.82.

Revenue	333.30M
Gross Profit	130.20M
Operating Income	-2.70M
Pretax Income	-53.90M
Net Income	-51.80M
EBITDA	14.69M
EBIT	-2.70M
Loss Per Share	-$0.82

Balance Sheet

The company has $39.35 million in cash and $273.30 million in debt, giving a net cash position of -$233.96 million or -$3.73 per share.

Cash & Cash Equivalents	39.35M
Total Debt	273.30M
Net Cash	-233.96M
Net Cash Per Share	-$3.73
Equity (Book Value)	344.98M
Book Value Per Share	4.92
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 39.06%, with operating and profit margins of -0.81% and -15.54%.

Gross Margin	39.06%
Operating Margin	-0.81%
Pretax Margin	-16.17%
Profit Margin	-15.54%
EBITDA Margin	4.41%
EBIT Margin	-0.81%
FCF Margin	n/a

Dividends & Yields

BIOX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.45%
Shareholder Yield	0.45%
Earnings Yield	-59.21%
FCF Yield	n/a

Analyst Forecast

The average price target for BIOX is $4.50, which is 226.09% higher than the current price. The consensus rating is "Buy".

Price Target	$4.50
Price Target Difference	226.09%
Analyst Consensus	Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a